Advanced development of LQ a liposome-based saponin-containing adjuvant for use in pansarbecovirus vaccines
Active Definitive Contract Awarded Last action
- Contract number
- 75N93023C00048
- Awardee
-
Institut De Formulation DES Vaccins (Ch) SA UEI N773KSZMJA78
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,193,365
Award facts
- Opportunity
-
- 75N93022R00009 Solicitation number
- Contract value 100% obligated
- $8,193,365.07 Current and potential, with all options
- Completion date 62% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 24 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Switzerland
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,256,273 | |
| Funding Only Action | -$26 | |
| Change Order | $2,000,000 | |
| Other Administrative Action | $0 | |
| Change Order | $1,143,117 | |
| Exercise an Option | $2,344,953 | |
| Original award | $1,449,048 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Institut De Formulation DES Vaccins (Ch) SA for advanced development of a liposome-based saponin-containing adjuvant for use in pansarbecovirus vaccines on September 30, 2023, with a ceiling value of $8,193,365.07.
The contract is firm fixed price with no set-aside. Place of performance is Switzerland. Work is scheduled for completion by September 29, 2028. The originating effort, issued under Executive Order 14398, focuses on advancing adjuvant formulation technology to enhance vaccine efficacy against emerging sarbecovirus threats.
Quick answers
Who was awarded contract 75N93023C00048?
75N93023C00048 was awarded to Institut De Formulation DES Vaccins (Ch) SA by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2023.
How much is contract 75N93023C00048 worth?
The government has obligated $8,193,365 on 75N93023C00048.
Was contract 75N93023C00048 competed?
The extent of competition for 75N93023C00048 was full and open competition. The government received 24 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award